Literature DB >> 9407373

Iris-color change developed after topical isopropyl unoprostone treatment.

T Yamamoto1, Y Kitazawa.   

Abstract

PURPOSE: To present a case in which iris pigmentation developed after treatment with isopropyl unoprostone, an analogue of a prostaglandin metabolite.
METHODS: Case report.
RESULTS: A Japanese man with dark brown irises, treated unilaterally with isopropyl unoprostone, developed iris-color change in the treated eye after a 20-month treatment.
CONCLUSIONS: Isopropyl unoprostone can induce iris pigmentation as does latanoprost.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9407373

Source DB:  PubMed          Journal:  J Glaucoma        ISSN： 1057-0829            Impact factor:   2.503


  10 in total

Review 1.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

Review 2.  A preliminary risk-benefit assessment of latanoprost and unoprostone in open-angle glaucoma and ocular hypertension.

Authors:  D L Eisenberg; C B Camras
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 3.  Prostaglandin analogues in the treatment of glaucoma.

Authors:  C Lindén; A Alm
Journal:  Drugs Aging       Date:  1999-05       Impact factor: 3.923

4.  Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide.

Authors:  A Hommer; B Kapik; N Shams
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

5.  Incidence of iris colour change in latanoprost treated eyes.

Authors:  M A Teus; E Arranz-Márquez; P Lucea-Suescun
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

6.  Comparison of iridial pigmentation between latanoprost and isopropyl unoprostone: a long term prospective comparative study.

Authors:  T Chiba; K Kashiwagi; N Chiba; K Ishijima; M Furuichi; S Kogure; K Abe; S Tsukahara
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

7.  Latanoprost-induced changes in the iris and trabeculum: an electron-microscopic morphological study.

Authors:  Nilgun Yildirim; Afsun Sahin; Selcuk Kara; Cengiz Baycu
Journal:  Int Ophthalmol       Date:  2009-01-13       Impact factor: 2.031

8.  Clinical options for the reduction of elevated intraocular pressure.

Authors:  Laura Crawley; Sohaib M Zamir; Maria F Cordeiro; Li Guo
Journal:  Ophthalmol Eye Dis       Date:  2012-04-30

Review 9.  Safety of unoprostone isopropyl as mono- or adjunctive therapy in patients with primary open-angle glaucoma or ocular hypertension.

Authors:  Paulo Augusto de Arruda Mello; Natalia C Yannoulis; Reza M Haque
Journal:  Drug Saf       Date:  2002       Impact factor: 5.228

Review 10.  An evidence-based review of unoprostone isopropyl ophthalmic solution 0.15% for glaucoma: place in therapy.

Authors:  Derrick S Fung; Jess T Whitson
Journal:  Clin Ophthalmol       Date:  2014-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.